Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of Gastrointestinal Oncology|July 11, 2024
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literatureCody Eslinger, Christina Wu, Daniel H AhnTherapeutic Advances in Gastroenterology|August 15, 2022
Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangementsDaniel Walden, Cody Eslinger, Tanios Bekaii-SaabJournal of Gastrointestinal Oncology|September 16, 2024
Spontaneous regression of advanced hepatocellular carcinoma following COVID-19 infection and vaccination: a case report and review of literatureCody Eslinger, Pedro Luiz Serrano Uson, Bolni Marius Nagalo, et al.Cureus|July 14, 2025
Navigating Severe Thrombocytopenia in End-Stage Liver Disease: A Pre-transplant Management DilemmaFares Jamal, Amani Elshaer, Cody Eslinger, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2023
Rechallenge With Switching Immune Checkpoint Inhibitors Following Autoimmune Myocarditis in a Patient With Lynch SyndromeCody Eslinger, Daniel Walden, Timothy Barry, et al.Drug Design, Development and Therapy|April 2, 2026
Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment ParadigmCody Eslinger, Mohamad Bassam Sonbol, Ben George, et al.Chinese Clinical Oncology|December 22, 2025
Response to DNA-damaging agents and PARP inhibitors in ATM mutated metastatic colorectal cancer: case seriesCody Eslinger, Daniel Walden, Mohamad Bassam Sonbol, et al.Gut|January 12, 2017
Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utilityErik S Knudsen, Uthra Balaji, Brian Mannakee, et al.Cell Reports|August 9, 2016
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic CancerAgnieszka K Witkiewicz, Uthra Balaji, Cody Eslinger, et al.Cancer|February 11, 2025
Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapyCody Eslinger, Daniel Walden, Alyssa McGary, et al.Pageof 2